Delaying Implementation of PMPRB’s Regulations an Opportunity to Protect Patient Access to Medicines and Vaccines Says Innovative Medicines Canada
OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Innovative Medicines Canada issued the following statement today in response to...